NasdaqCM - Nasdaq Real Time Price USD

Dyadic International, Inc. (DYAI)

0.3799 +0.0401 (+11.80%)

As of 11:38:00 AM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026

GlobeNewswire 9d ago

DYAI
+11.80%
DYAI: Second Quarter Results

Zacks Small Cap Research 2mo ago

DYAI
+11.80%
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement

GlobeNewswire 2mo ago

DYAI
+11.80%
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas

GlobeNewswire 2mo ago

DYAI
+11.80%
Dyadic Announces Continued Listing on the Nasdaq Capital Market

GlobeNewswire 3mo ago

DYAI
+11.80%
^IXIC
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program

GlobeNewswire 3mo ago

DYAI
+11.80%
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

GlobeNewswire 4mo ago

DYAI
+11.80%
Dyadic Expands IP Protection and Business Development Activities in Japan

GlobeNewswire 4mo ago

DYAI
+11.80%
An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets

TMX Newsfile 4mo ago

DYAI
+11.80%
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

GlobeNewswire 4mo ago

DYAI
+11.80%
Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

GlobeNewswire 5mo ago

DYAI
+11.80%
Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

GlobeNewswire 5mo ago

DYAI
+11.80%

Performance Overview

Return	DYAI	S&P 500 (^GSPC)
YTD	-58.74%	+9.81%
1-Year	-58.30%	+11.72%
3-Year	-75.76%	+72.91%

U.S. markets close in 4h 15m

Dyadic International, Inc. (DYAI)

Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026

DYAI: Second Quarter Results

Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas

Dyadic Announces Continued Listing on the Nasdaq Capital Market

Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

Dyadic Expands IP Protection and Business Development Activities in Japan

An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026